IT201700002235A1 - Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general - Google Patents

Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general

Info

Publication number
IT201700002235A1
IT201700002235A1 IT102017000002235A IT201700002235A IT201700002235A1 IT 201700002235 A1 IT201700002235 A1 IT 201700002235A1 IT 102017000002235 A IT102017000002235 A IT 102017000002235A IT 201700002235 A IT201700002235 A IT 201700002235A IT 201700002235 A1 IT201700002235 A1 IT 201700002235A1
Authority
IT
Italy
Prior art keywords
diabetes
treatment
composition
general
oral administration
Prior art date
Application number
IT102017000002235A
Other languages
Italian (it)
Inventor
Tullio Romussi
Original Assignee
Arche Frama Srls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arche Frama Srls filed Critical Arche Frama Srls
Priority to IT102017000002235A priority Critical patent/IT201700002235A1/en
Publication of IT201700002235A1 publication Critical patent/IT201700002235A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IT102017000002235A 2017-06-07 2017-06-07 Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general IT201700002235A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000002235A IT201700002235A1 (en) 2017-06-07 2017-06-07 Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000002235A IT201700002235A1 (en) 2017-06-07 2017-06-07 Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general

Publications (1)

Publication Number Publication Date
IT201700002235A1 true IT201700002235A1 (en) 2018-12-07

Family

ID=60293988

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000002235A IT201700002235A1 (en) 2017-06-07 2017-06-07 Composition for oral administration useful in the treatment of diabetes and metabolic syndrome in general

Country Status (1)

Country Link
IT (1) IT201700002235A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025349A1 (en) * 2000-05-02 2002-02-28 Brindavanam Narasimha Baba Novel herbal composition for diabetes patients and a process for producing the same
US20160296577A1 (en) * 2013-10-28 2016-10-13 Piramal Enterprises Limited Herbal composition, process for its preparation and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025349A1 (en) * 2000-05-02 2002-02-28 Brindavanam Narasimha Baba Novel herbal composition for diabetes patients and a process for producing the same
US20160296577A1 (en) * 2013-10-28 2016-10-13 Piramal Enterprises Limited Herbal composition, process for its preparation and use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DHANABAL S P ET AL: "Hypoglycaemic activity of Pterocarpusmarsupium Roxb", PHYTOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, vol. 20, no. 1, 1 January 2006 (2006-01-01), pages 4 - 8, XP009503305, ISSN: 0951-418X, [retrieved on 20060105], DOI: 10.1002/PTR.1819 *
GUPTA R ET AL: "Protective role of Pterocarpus marsupium in diabetes-induced hyperlipidemic condition", JOURNAL OF COMPLEMENTARY AND INTEGRATIVE MEDICINE, BERKELEY ELECTRONIC PRESS, UK, vol. 6, no. 1, 1 January 2009 (2009-01-01), XP009503312, ISSN: 1553-3840 *
JUN LIU ET AL: "Chromium, Selenium, and Zinc Multimineral Enriched Yeast Supplementation Ameliorates Diabetes Symptom in Streptozocin-Induced Mice", BIOLOGICAL TRACE ELEMENT RESEARCH, HUMANA PRESS INC, NEW YORK, vol. 146, no. 2, 12 November 2011 (2011-11-12), pages 236 - 245, XP035033321, ISSN: 1559-0720, DOI: 10.1007/S12011-011-9248-X *
QIXUAN CHEN ET AL: "Nutrient Metabolism Bitter Melon (Momordica charantia) Reduces Adiposity, Lowers Serum Insulin and Normalizes Glucose Tolerance in Rats Fed a High Fat Diet 1", 1 January 2003 (2003-01-01), XP055358559, Retrieved from the Internet <URL:http://jn.nutrition.org/content/133/4/1088.full.pdf#page=1&view=FitH> [retrieved on 20170324] *

Similar Documents

Publication Publication Date Title
DOP2018000297A (en) DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION THAT INCLUDES THE SAME AND THERAPEUTIC USE OF THE SAME
BR112018076601A2 (en) oral pharmaceutical formulation, methods for treating a patient, and use of a formulation
BR112018004532A2 (en) use of pasteurized akkermansia for the treatment of metabolic disorders
CL2016001609A1 (en) Pharmaceutical compositions comprising azd9291.
AR098738A1 (en) ANALOGS OF THE EXENDINE PEPTIDE-4 NOT CLOSED
CL2014000956A1 (en) Compounds derived from (4-phenylimidazol-2-yl) ethylamine, such as sodium channel modulators; pharmaceutical composition that includes them; and its use in the treatment of pain.
BR112016019592A8 (en) COMPOUND, USE OF A COMPOUND, AND, PHARMACEUTICAL COMPOSITION
CL2016001587A1 (en) Derivative based on 1,2-naphthoquinone and method of preparation thereof.
CL2019001214A1 (en) Pharmaceutical composition, methods for treatment and their uses.
EA202191513A1 (en) REDUCING THE VISCOSITY OF PHARMACEUTICAL COMPOSITIONS
DK3098224T3 (en) PYRANOCHROMENYL PHENOLER DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME OR INFLAMMATION DISEASE
IT201600121601A1 (en) ORAL COMPOSITION FOR THE TREATMENT OF GASTROESOFAGEO REFLUX AND LARINGO-FARINGEO REFLUX
BR112017012406A2 (en) fixed ratio formulation of insulin glargine / lixisenatide
ECSP16086247A (en) (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
BR112017021190A2 (en) pharmaceutical composition and its use
DK3275455T3 (en) PHARMACEUTICAL COMPOSITION WITH SILIBININE AND L-CARNITINE
CR20170376A (en) TREATMENT OF PEDIATRIC PATIENTS WITH MELLITUS DIABETES OF TYPE 2 WITH LIXISENATIDA
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
IT201600081379A1 (en) Pharmaceutical composition for use in the treatment of prostatic diseases.
MX2020004513A (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same.
MD4763B1 (en) Pharmaceutical composition
EA201700254A1 (en) COMBINATION
BR112019017314A2 (en) pharmaceutical compositions for combination therapy